MPM Capital raises $900m for biotech ventures fund

MPM Capital, a venture capital firm with offices in Boston, San Francisco and Munich, has completed $900m (€891m) of fundraising on its biotech fund, making it one of the largest early stage funds raised this year.

Investors were mostly US-based for the firm's third fund, BioVentures III, which is dedicated to healthcare start-ups. It will invest $5m to $60m in companies in the US, Europe and Asia.

WSJ Logo
Pro Bono or Pro Nono? Law Firms Split on Fulfilling Deals With TrumpExternal link

Pro Bono or Pro Nono? Law Firms Split on Fulfilling Deals With Trump